ENDRA Life Sciences Inc..
NDRA.US | Manufacture of medical and dental instruments and supplies
ENDRA Life Sciences Inc. is a medical technology company focused on developing and commercializing innovative diagnostic imaging technologies. Their primary focus is on Thermo Acoustic Enhanced UltraSound (TAEUS®), a technology designed to visualize tissue composition and function at the point of ca...Show More
Better Health for All
20
ENDRA Life Sciences' core business is entirely focused on developing and commercializing TAEUS technology for the early detection and management of steatotic liver disease (SLD), also known as NAFLD/NASH.
1
This condition affects over 2 billion people globally and is linked to severe chronic conditions like obesity, type 2 diabetes, cardiovascular disease, and liver cancer.
2
Early detection is crucial for reversibility, as the disease can progress to irreversible fibrosis, cirrhosis, and cancer.
3
The company's entire product portfolio is dedicated to addressing this widespread health issue, aiming to fill a critical gap in dependable, affordable, and easily accessible point-of-care diagnostics.
4
There is no evidence of any products or activities with negative health outcomes. While the TAEUS technology is stated to be 50 times less expensive than MRI-PDFF (the current gold standard, costing over $2,500 per exam) and offered via a subscription model with no upfront capital expenditures,
5
the rubric's quantitative thresholds for price accessibility are based on a multiple of production cost, which is not provided. Similarly, for vulnerable reach, health innovation investment, preventative health measures, healthcare data responsibility, and clinical trial ethics, the evidence describes the company's focus, plans, or general compliance (e.g., ISO certification, privacy policy, R&D into new frontiers), but lacks the specific quantitative data points required by the rubric's thresholds to assign a score.
Fair Money & Economic Opportunity
0
No evidence available to assess ENDRA Life Sciences Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess ENDRA Life Sciences Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Fair Trade & Ethical Sourcing. The articles either explicitly stated a lack of relevant information, indicated that the requested content was not found, or were general directories not specific to ENDRA Life Sciences Inc.'s ethical sourcing practices.
Honest & Fair Business
0
No evidence available to assess ENDRA Life Sciences Inc. on Honest & Fair Business.
Kind to Animals
-40
ENDRA Life Sciences Inc. engages in animal testing for medical analysis and clinical research, as explicitly stated by their Chief Technology Officer, Michael Thornton, regarding the use of preclinical animal models.
1
No information is provided regarding a formal policy to reduce or replace animal testing, or any commitment to measurable goals or accountability in this area.
2
No War, No Weapons
0
No evidence available to assess ENDRA Life Sciences Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles do not contain specific, concrete data points for any of the Planet-Friendly Business KPIs. Information regarding emissions, targets, renewable energy, water use, waste, certifications, or environmental compliance violations is explicitly stated as 'no data' or 'not mentioned' across the available sources.
1
Therefore, no KPIs can be scored based on the strict evidence requirements.
Respect for Cultures & Communities
0
No evidence available to assess ENDRA Life Sciences Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess ENDRA Life Sciences Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points for NDRA.US related to any of the 'Zero Waste & Sustainable Products' KPIs were found in the provided articles.
1
Information regarding other companies or general market trends was present but not applicable to NDRA.US.
2